Inhibition of proprotein convertase subtilisin/kexin type 9 (PCSK9): A new approach in lipid lowering treatment
Journal Title: Αρχεία Ελληνικής Ιατρικής - Year 2015, Vol 32, Issue 1
Abstract
Cardiovascular disease is the single most common cause of death worldwide; hence its prevention constitutes a strategic target for the improvement of life expectancy and quality of life. Statins have been an essential element of lipid lowering treatment for decades, with undisputable results. Some patients, however, either cannot tolerate statins or cannot achieve the goal of lipid lowering by statins alone. The study of people with genetically high or low cholesterol levels and analysis of their genome has led to the discovery of the proprotein convertase subtilisin/kexin type 9 (PCSK9) protein. The important contribution of the PCSK9 in the catabolism of the low density lipoprotein (LDL) receptor renders it the main regulator in the metabolism of cholesterol, thus making it an attractive target for the development of new lipid lowering drugs. Inhibition of the PCSK9 protein by the use of monoclonal antibodies is the most advanced approach. This achieves an additional reduction of LDL cholesterol by 50% while having a good safety profile. Pending the completion of further studies, it already appears that we are witnessing a revolution in the field of lipid lowering treatment and prevention of cardiovascular disease.
Authors and Affiliations
E. KLOURAS, M. ELISAF
Keywords
Related Articles
- EP ID EP147922
- DOI -
- Views 52
- Downloads 0
Acute anuria due to solitary renal artery occlusion
No abstract available
Πρόληψη θρομβοεμβολικών επεισοδίων επί κολπικής μαρμαρυγής
Η κολπική μαρμαρυγή (ΚΜ) αποτελεί τη συχνότερη κλινικά σημαντική αρρυθμία, η οποία συνδέεται με αυξημένη νοσηρότητα και θνησιμότητα λόγω καρδιαγγειακών επεισοδίων. Η συχνότητα της ΚΜ στο γενικό πληθυσμό είναι 1% και αυξά...
Cost- and time-effectiveness of application of MALDI-TOF mass spectrometry methodology in a food and water microbiology laboratory
No abstract available
Juvenile spondyloarthritis: The criteria that do not unravel the problem of a complicated diagnosis
Spondyloarthritis (SpA) encompasses a group of inflammatory joint diseases with overlapping features that accounts for up to 15–20% of cases of arthritis in children. In children, SpA at onset is often undifferentiated a...
Lactate ringer solution
NO abstract available